You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

FOLEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Folex, and when can generic versions of Folex launch?

Folex is a drug marketed by Pharmacia And Upjohn and is included in four NDAs.

The generic ingredient in FOLEX is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Folex

A generic version of FOLEX was approved as methotrexate sodium by HIKMA on September 16th, 1986.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FOLEX?
  • What are the global sales for FOLEX?
  • What is Average Wholesale Price for FOLEX?
Summary for FOLEX
US Patents:0
Applicants:1
NDAs:4
Raw Ingredient (Bulk) Api Vendors: 137
DailyMed Link:FOLEX at DailyMed
Drug patent expirations by year for FOLEX

US Patents and Regulatory Information for FOLEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn FOLEX methotrexate sodium INJECTABLE;INJECTION 087695-001 Apr 8, 1983 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn FOLEX methotrexate sodium INJECTABLE;INJECTION 088954-001 Oct 24, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn FOLEX methotrexate sodium INJECTABLE;INJECTION 087695-002 Apr 8, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn FOLEX methotrexate sodium INJECTABLE;INJECTION 087695-003 Apr 8, 1983 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn FOLEX PFS methotrexate sodium INJECTABLE;INJECTION 089180-001 Jan 3, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn FOLEX PFS methotrexate sodium INJECTABLE;INJECTION 081242-001 Aug 23, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.